1. Home
  2. VRRM vs HRMY Comparison

VRRM vs HRMY Comparison

Compare VRRM & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verra Mobility Corporation

VRRM

Verra Mobility Corporation

HOLD

Current Price

$13.46

Market Cap

2.0B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$30.14

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRRM
HRMY
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
VRRM
HRMY
Price
$13.46
$30.14
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$25.90
$44.11
AVG Volume (30 Days)
1.7M
693.2K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
347.37
7.97
EPS
0.17
0.55
Revenue
$132,969,000.00
$868,453,000.00
Revenue This Year
$6.84
$19.75
Revenue Next Year
$6.88
$12.88
P/E Ratio
$78.68
$55.53
Revenue Growth
14.61
21.51
52 Week Low
$12.83
$25.52
52 Week High
$25.83
$40.87

Technical Indicators

Market Signals
Indicator
VRRM
HRMY
Relative Strength Index (RSI) 35.41 46.73
Support Level N/A $28.26
Resistance Level $15.55 $30.96
Average True Range (ATR) 0.56 1.10
MACD -0.04 -0.17
Stochastic Oscillator 30.42 30.51

Price Performance

Historical Comparison
VRRM
HRMY

About VRRM Verra Mobility Corporation

Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe, and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three reportable segments: Commercial Services, Government Solutions, and Parking Solutions. Maximum revenue is generated from the Commercial Services segment, which offers toll and violation management solutions and title and registration services for commercial fleet customers, including RACs and FMCs in North America. In Europe, it provides tolling and violations processing services.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: